We are live on
!
Find out more
3C
325 Capital Portfolio holdings
AUM
$419M
1-Year Est. Return
75.74%
This Fund
S&P 500
This Quarter
Est. Return
-12.07%
1 Year Est. Return
+75.74%
3 Year Est. Return
+225.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$285M
AUM Growth
-$43.7M
(-13%)
Cap. Flow
-$4.65M
Cap. Flow
% of AUM
-1.63%
Top 10 Holdings %
Top 10 Hldgs %
94.58%
Holding
13
New
1
Increased
4
Reduced
2
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Magnite
MGNI
|
+$22.5M |
| 2 |
Astrana Health
ASTH
|
+$17.1M |
| 3 |
MultiSensor AI
MSAI
|
+$12.5M |
| 4 |
Diebold Nixdorf
DBD
|
+$12.1M |
| 5 |
AIOT
PowerFleet Inc
AIOT
|
+$978K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astronics
ATRO
|
+$64.9M |
| 2 |
Blue Bird Corp
BLBD
|
+$4.88M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.33% |
| 2 | Consumer Staples | 20.24% |
| 3 | Industrials | 17.45% |
| 4 | Technology | 15.84% |
| 5 | Communication Services | 11.4% |
Similar funds
PWA
BA
UOC
RBFC
LSWP
XWM
NTCM
DAS
325 Capital's Q4 2025 Portfolio in Review
As of Q4 2025, 325 Capital held 13 positions worth $285M, down 13% from $329M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
325 Capital's Q4 2025 filing shows 1 new, 4 increased and 2 reduced positions. Its largest new stake was Diebold Nixdorf: 193,401 shares worth $13.1M. The largest sale was Astronics, an estimated $64.9M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Industrials.
- 325 Capital's largest Q4 2025 buy was Diebold Nixdorf: 193,401 shares worth $13.1M.
- 325 Capital added most to Magnite in Q4 2025, an estimated $22.5M increase.
- 325 Capital's biggest Q4 2025 reduction was Astronics, cutting an estimated $64.9M.
- 325 Capital's ten largest holdings make up 95% of its $285M portfolio in Q4 2025.
- 325 Capital opened 1 new position and closed 0 in Q4 2025.
- 325 Capital's portfolio value fell 13% quarter-over-quarter to $285M.
Based on 325 Capital's 13F filing for Q4 2025, filed 17 Feb 2026.